The Virtual NP Review
Best for: Patients in served states wanting affordable visits and FDA-approved branded GLP-1s
The Virtual NP is a nurse-practitioner-led telehealth weight loss clinic prescribing FDA-approved branded GLP-1 medications, Zepbound (tirzepatide) and Wegovy (semaglutide), from Eli Lilly and Novo Nordisk. It does not offer compounded versions. Pricing is a 99 dollar pay-as-you-go visit or a 75 dollar per month membership that includes prescription access, with medication cost billed separately and disclosed upfront. HSA/FSA is accepted and prior authorization help is offered. Founder Sandra Jordan, MSN, APRN, FNP-C, leads the practice. Most patients book within 24 hours, with home shipping.
High confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
The Virtual NP is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
The Virtual NP prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Zepbound branded, plus medication cost | brand | $75 |
| Wegovy branded, plus medication cost | brand | $75 |
✓ Pros
- •FDA-approved branded Zepbound and Wegovy only, no compounded
- •Transparent fees: 99 visit or 75 per month membership
- •HSA/FSA accepted and prior authorization assistance offered
- •NP-led with same or next-day booking and home shipping
✗ Cons
- •Branded only, so medication cost is high and billed separately
- •Limited to seven states
- •No compounded lower-cost GLP-1 alternative
- •Single-provider practice may limit scale and hours
Ready to start with The Virtual NP?
Starting at $75/month. See current pricing and start your free consultation.
Sources & methodology
Our The Virtual NP review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to The Virtual NP
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with The Virtual NP?
Starting at $75/month. See current pricing and start your free consultation.